A comprehensive view of Hospital/Clinical Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Biogen’s staff count at Cambridge, Massachusetts, site drops by 301 employees since first of the year reports Boston Business Journal; Biogen to lay off as many as 1,000 employees in US$1B cost-cutting plan due to failure of Aduhelm Alzheimer’s drug

Jury orders Eli Lilly to pay over US$61.0M in damages in whistleblower lawsuit alleging Lilly underpaid Medicaid drug rebates; False Claims Act allows damages to be tripled, with final judgement possibly to be more than US$183.0M

Amgen reports Q2 net income up at US$1.3B from US$464.0M a year ago, with total revenues up 1% to US$6.6B; results driven by 3% growth in global product sales, double-digit growth in a number of products including Repatha, Prolia, Evenity

AmerisourceBergen reports fiscal year 2022 Q3 GAAP net income up at US$407.0M from US$292.1M a year ago, with revenue up 12.5% year-over-year to US$60.1B; growth driven by 120.3% increase in International Healthcare Solutions revenue

Lilly reports Q2 net income down at US$952.5M from US$1.4B a year ago, with revenue down 4% year-over-year to US$6.5B; Q2 US revenue up 6% to US$3.9B driven by 14% increase in volume, offset by 8% decrease from lower realized prices

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count